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Abstract
Regulatory agencies require testing of chemicals and products to protect workers and consumers 
from potential eye injury hazards. Animal screening, such as the rabbit Draize test, for potential 
environmental toxicants is time-consuming and costly. Therefore, virtual screening using 
computational models to tag potential ocular toxicants is attractive to toxicologists and policy 
makers. We have developed quantitative structure–activity relationship (QSAR) models for a set of 
small molecules with animal ocular toxicity data compiled by the National Toxicology Program 
Interagency Center for the Evaluation of Alternative Toxicological Methods. The data set was 
initially curated by removing duplicates, mixtures, and inorganics. The remaining 75 compounds 
were used to develop QSAR models. We applied both k nearest neighbor and random forest 
statistical approaches in combination with Dragon and Molecular Operating Environment 
descriptors. Developed models were validated on an external set of 34 compounds collected from 
additional sources. The external correct classification rates (CCR) of all individual models were 
between 72 and 87%. Furthermore, the consensus model, based on the prediction average of 
individual models, showed additional improvement (CCR = 0.93). The validated models could be 
used to screen external chemical libraries and prioritize chemicals for in vivo screening as 
potential ocular toxicants.
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The Draize test has been used as a standard testing protocol to evaluate ocular toxic potential 
of chemicals since it was developed in the 1940s.1 In this test, chemicals are applied to 
rabbit eyes, and the ocular responses are scored based on the damage to the cornea, iris, and 
conjunctiva. The Draize test has been applied by different regulatory agencies and 
pharmaceutical companies to evaluate the ocular toxicity of chemicals.2 Different agencies 
have their own scoring system to define the ocular toxicants. For example, the United Nation 
Globally Harmonized System (GHS),3 the U.S. Environmental Protection Agency (U.S. 
EPA) classification system,4 and the European Union (EU) classification system5 are three 
major regulatory criteria used for ocular hazard classification based on the Draize test 
results.
As one of the animal test protocols, the Draize test has the common disadvantages of other 
animal tests, such as being expensive and time-consuming. Furthermore, because the test 
rabbits need to be euthanized if the test uses irreversible damage to the eyes, the Draize test 
has been criticized for its cruelty.2 For this reason, alternative methods to evaluate the 
chemical ocular toxicity are in high demand. Since the 1990s, substantial efforts have been 
made to develop alternative in vitro methods to reproduce and predict eye irritation 
responses in the Draize test. For example, the National Toxicology Program (NTP) 
Interagency Center for the Evaluation of Alternative Toxicological Methods (NICEATM) 
and the Interagency Coordinating Committee on the Validation of Alternative Methods 
(ICCVAM) gathered various in vitro methods to evaluate chemical ocular toxicity. The 
NICEATM and ICCVAM have also executed validating studies to assess the reliability of 
these testing protocols.6 Five of these methods were recently recommended by ICCVAM as 
potential alternatives to the Draize test.7 However, currently available in vitro toxicity assays 
have several limitations: they all require physical samples of compounds for testing, and 
despite significant technical advances of the ICCVAM ocular toxicity assays, they require 
animal eyes as the testing tissues and still remain time-consuming and resource-intensive.
As compared to experimental testing protocols, the computational tools that could be used to 
evaluate potential chemical toxicity are almost of no cost and applicable for virtual 
compounds before they are synthesized. Quantitative structure–activity relationship (QSAR) 
analysis is a widely used computational method to generate models and predict the toxicity 
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of chemicals. In QSAR studies, the quality of the resulting models strongly depends on the 
chemical descriptors and the modeling approaches that are employed. Early efforts in the 
QSAR modeling of chemical ocular toxicity were based on the simple linear regression 
method and empirical descriptors (e.g., physicochemical properties).8,9 The models of this 
type are easy to implement and explain due to their simplicity, but their utility is limited to 
compounds that are highly similar to the modeling set. Later on, more sophisticated 
modeling approaches and descriptors have also been applied in this area. For example, 
Hopfinger and his co-workers used a membrane-simulated model to study ocular 
toxicity.10–13 They identified a set of empirical descriptors that strongly correlate to cornea 
permeability. Then, the same descriptor pool was used to develop an eye irritation model. 
For a summary of modeling studies in this area, please see the previously published 
reviews.14,15
Because of the limited availability of ocular toxicity data, very few of the previously 
published models were validated on external compounds. Most of the studies were based on 
the Draize test data instead of considering regulatory scoring systems. Furthermore, because 
only one type of descriptor and one modeling approach was used in most of the previous 
studies, the direct comparison of models is not possible. This paper addresses these 
challenges by applying the combinatorial QSAR (combi-QSAR) approach16 to an ocular 
toxicity data set recently compiled by ICCVAM. The compounds in this data set have been 
extensively studied by different regulatory agencies. We used several different combinations 
of various chemical descriptors and modeling approaches (so-called combi-QSAR 
approach). All of the resulting models were validated on a separately compiled external set. 
Previous combi-QSAR studies16–18 suggest that it is impossible to decide a priori which 
particular combination of a modeling method and a descriptor set will prove most 
successful. Thus, the consensus model (i.e., averaging of the results of all individual combi-
QSAR models) is the best alternative, which usually outperforms individual models.16–18 In 
this study, the consensus model has clear improvement in predictivity and coverage. We 
expect to use the resulting models as a virtual screening tool to prioritize new compounds 
for future experimental testing.
MATERIALS AND METHODS
Data Sets
The ocular toxicity data set used in this study was obtained from the ICCVAM.6 The original 
data set contains the ocular toxicity results of 232 agents. All of the agents have been tested 
by the Draize test and have scores from at least one of the three regulatory scoring systems 
(GHS, U.S. EPA, and EU). However, about 50% of the agents are duplicates or substances 
without defined chemical structures. Furthermore, inorganic compounds and mixtures 
cannot be properly represented by chemical descriptors. After these compounds were 
removed as unsuitable for modeling, we had 75 unique organic compounds remaining out of 
the original ICCVAM data set.
In different regulatory scoring systems, different terminologies were used to represent the 
categories of ocular toxicants. Generally, the compounds could be classified as (1) severe 
ocular toxicants (category 1 of GHS, category I of U.S. EPA, and R41 of EU); (2) moderate 
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ocular toxicants (category 2A of GHS, category II of U.S. EPA, and R36 of EU); (3) light 
ocular toxicants (category 2B of GHS and category III of U.S. EPA); and (4) nontoxicants 
(nonirritant of GHS, category IV of U.S. EPA, and nonirritant of EU). Because the “light 
ocular toxicants” defined by GHS (category 2B) and U.S. EPA (category III) are mostly 
“nonirritant” in EU results (except N-octanol in our data set), it is reasonable to define the 
severe and moderate ocular toxicants as “actives” and the light ocular toxicants and 
nontoxicants as “inactives”. On the basis of this rule, we defined a composite category for 
this study out of the three scoring systems (Table 1).
Using the composite classification as defined above, the ocular toxicity results from these 
three scoring systems are highly correlated with each other. Among the 75 ICCVAM 
compounds, 30 compounds are active, and 40 compounds are inactive in all of the sources 
(100 and 0% active data ratio, respectively, in Figure 1). The only five compounds that have 
conflicting results we defined as “actives” since all of them have at least one “moderate 
toxic” result (Figure 1). This 75 compound data set was then used to develop the QSAR 
models in this study.
From the previous ocular toxicity studies, we compiled an external set from two reports. 
Takahashi and his co-workers recently studied the correlation between the results of a short 
time bioassay and the GHS scores for a small set of compounds.19 Within this data set, 21 
out of 44 compounds are not in the ICCVAM data set. The GHS scores of these 21 new 
compounds could be classified as 17 actives and four inactives based on the criteria 
mentioned above. In another study, Kulkarni and his co-workers developed a predictive 
ocular toxicity model of 37 compounds with their molar adjusted eye scores calculated from 
relevant Draize test results.10 There are 13 out of 37 compounds that are new to us, and all 
of them are inactives based on our definitions. As a result, we have a 34 compound external 
set (17 actives and 17 inactives) that could be used to validate our resulting models since all 
of these compounds do not exist in the ICCVAM data set and are “unknown” to the resulting 
models. The compounds in the modeling and external sets are available in Tables 1 and 2 in 
the Supporting Information.
Chemical Descriptors
Chemical ocular toxicity models for the 75 ICCVAM compounds were developed with 
various types of 2D chemical descriptors, from Dragon (version 6)20 and MOE (version 
2011).21 The types of MOE descriptors include topological indices, structural keys, E-state 
indices, physical properties (such as Log P, molecular weight, and molar refractivity), and 
topological polar surface area. The types of Dragon descriptors included in this study are E-
state values and E-state counts, constitutional descriptors, topological descriptors, walk and 
path counts, connectivity and information indices, 2D autocorrelations, Burden eigenvalues, 
molecular properties (such as the octanol–water partition coefficient), Kappa, hydrogen 
bond acceptor/donor counts, molecular distance edge, molecular fragment counts, and 
chemical fingerprints. There are overlaps between Dragon descriptors and MOE descriptors, 
but both included unique types of descriptors as well. Initially, Dragon software yielded over 
2000 chemical descriptors for the training set. Redundant descriptors were identified by 
analyzing correlations coefficients between all pairs of descriptors, and if the correlation 
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coefficient between two descriptors was higher than 0.99, one of them was randomly 
removed. As a result, the total number of Dragon descriptors used in model building was 
reduced to 493. Because the number of MOE descriptors is much less than the Dragon 
descriptors, we used all 186 available MOE descriptors in our modeling process.
Universal Statistical Figures of Merit for All Models
Because we employed different modeling approaches and different descriptors in the 
modeling process (described below), universal statistical metrics are needed to evaluate the 
performance of models developed independently for the ICCVAM set. To harmonize the 
results of this study, we used sensitivity (the percentage of experimental toxicants that are 
predicted correctly), specificity (the percentage of experimental nontoxicants that are 
predicted correctly), and correct classification rate (CCR) to evaluate the predictions. These 




k Nearest Neighbor (kNN)
The kNN QSAR method22 employs the kNN classification principle and the variable 
selection procedure. Briefly, a subset of nvar (number of selected variables) descriptors is 
selected randomly at the onset of the calculations. The nvar is set to different values, and the 
training set models are developed with leave-one-out cross-validation, where each 
compound is eliminated from the training set and its ocular toxicity is predicted as the 
average activity of k most similar molecules where the value of k is optimized as well (k = 
1–5). The similarity is characterized by Euclidean distance between compounds in 
multidimensional descriptor space. A method of simulated annealing with the Metropolis-
like acceptance criteria is used to optimize the selection of variables. The objective of this 
method is to obtain the best leave-one-out cross-validated (LOO-CV) CCR possible by 
optimizing the nvar and k. Additional details can be found elsewhere.22
Following our general QSAR modeling workflow methodology,23 all of the kNN models 
were extensively validated. The modeling compounds were divided multiple times into 
training/test sets using the Sphere Exclusion approach.24 The statistical significance of the 
models was characterized with the standard LOO-CV CCR for the training sets and the 
conventional CCR for the test sets. The model acceptability cutoff values of the LOO-CV 
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accuracy of the training sets and the prediction accuracy for test sets were both set at 0.7. 
Models that did not meet both training and test set cutoff criteria were discarded. The 
discussion of the workflow used to develop validated QSAR models is given in a recent 
review.25
Random Forest (RF)
In machine learning, a RF is a predictor that consists of many decision trees and outputs the 
prediction that combines outputs from individual trees. The algorithm for inducing a random 
forest was developed by Breiman and Cutler.26 In this study, the implementation of the 
random forest algorithm available in R.2.15.127 was used. In the RF modeling procedure, n 
samples are randomly drawn from the original data. These samples were used to construct n 
training sets and to build n trees. For each node of the tree, m variables were randomly 
chosen from the all of the available chemical descriptors (e.g., the 493 Dragon descriptors). 
The best data split was calculated using the m variables for the modeling set. In this study, 
only the defined parameters (n = 500 and m = 13) were used for model development.
Combinatorial QSAR
The whole workflow of the modeling process is shown in Figure 2. The individual 
classification models were developed using the combination of one type of descriptors 
(Dragon or MOE) and one type of modeling tools (kNN or RF), resulting in four different 
models: Dragon-RF (D-R), Dragon-kNN (D-k), MOE-RF (M-R), and MOE-kNN (M-k). 
The consensus model was generated as the average of the prediction values of the individual 
models.
RESULTS AND DISCUSSION
Overview of the ICCVAM and External Data Sets
We could analyze the chemical space of our data set, including both ICCVAM and external 
compounds, by performing principle component analysis (PCA) of the chemical descriptors 
used in this study. After PCA with the 186 MOE descriptors for all of the compounds in 
both modeling (ICCVAM) and external validation sets, we selected the first three most 
important components to generate a three-dimensional plot (Figure 3) for these 109 (75 
modeling and 34 validation) compounds. This plot could be viewed as the chemical space 
covered by the compounds used in this study. We noticed two structural outliers in our data. 
The one in the modeling set is polyethylene glycol 400 (CAS Registry Number: 
25322-68-3), widely used in a variety of pharmaceutical formulations due to its low toxicity. 
However, although it is a low molecular weight grade of polyethylene glycol, there is no 
other similar polymer in our data set. Similarly, there is a structural outlier, Acid red 92 
(CAS Registry Number: 18472-87-2), existing in our external validation set. Excluding 
structural outliers from the modeling set may improve robustness of QSAR models,17 while 
outliers in the external set should be detected by model's applicability domain.18,28 This 
study, however, is limited by the relatively small size of the modeling set and could not 
demonstrate the advantage of using applicability domain (data not shown). However, when 
additional data becomes available in the future, this critical issue needs to be considered to 
develop enhanced models.
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The prediction results of all four individual models and the consensus model for the 34 
external compounds (17 toxicants and 17 nontoxicants) are shown in Figure 4. The 
sensitivity, specificity, and CCR were 0.82, 0.82–0.92, and 0.85–0.88, respectively, for all 
four individual models, respectively. Only the RF-MOE model has relatively low accuracy 
(CCR = 0.73). Because the number of nontoxicants is higher than the toxicants in our 
modeling set (40 nontoxicants vs 35 toxicants), the prediction accuracy of the external 
nontoxicants (specificity) by all of the resulting models is somewhat higher than the 
predictivity of the external toxicants (sensitivity) (Figure 4). In several of our previous 
studies, we indicated that a consensus model (based on the predictions averaged over all 
available individual models) has better performance when compared to most individual 
modes.17,18,28,29 Moreover, for the consensus model, there is no need to decide which model 
to use out of several equally performing ones. In this study, our consensus model was based 
on the average of all four individual models. The prediction result of the external set shows 
that the consensus model has better predictivity for both toxicants (sensitivity of 0.88) and 
nontoxicants (specificity of 1) (Figure 4).
To compare the resulting models with existing computational tools, we have used the eye 
irritation module of the current Organisation for Economic Co-operation and Development 
(OECD) QSAR Toolbox30 to predict the same external compounds. There are only two 
external compounds, 2-methyl-1-pentanol and 3-methoxy-1,2-propanediol, that were 
identified as having structural alerts of ocular toxicity. The 2-methyl-1-pentanol is toxic, but 
the 3-methoxy-1,2-propanediol is actually nontoxic. The remaining compounds were 
identified as having “undefined functional groups”. For this reason, the prediction results of 
external compounds by our models are better than the results obtained from the OECD 
QSAR Toolbox eye irritation module.
Interpretation of Predictive QSAR Models
To obtain relevant toxicity mechanisms from our modeling results, we chose to analyze 
Dragon descriptors for their diversity and kNN models for their ease of interpretation (by 
frequency of descriptor occurrence). Several descriptors were found to be most frequently 
used in the kNN models that satisfied our criterions (CCR > 0.7 for both training and 
relevant test sets), suggesting that they may play a critical role in predicting ocular toxicity 
of organic compounds. The most important Dragon descriptors used in the kNN modeling 
approach are shown in Table 2, along with their frequencies of occurrence in acceptable 
models and their interpretations (Table 2). The first important descriptor refers to alcohols, 
which may cause mild to severe eye irritation.31–34 There are three druglike index 
descriptors that are considered to be important in our models. These types of descriptors 
were created based on Ghose–Viswanadhan–Wendoloski's (GVW) consensus definitions of 
drug classes.35 They identified drug classes using calculated physiochemical properties. 
Many pharmaceutical drugs have eye-related side effects, including dry eye, pupil dilation, 
retinal damage, and reduced acuity.36 The descriptor 3 represents anti-infective drugs. 
Within this drug category, the ophthalmic solutions have been known to cause acute corneal 
epithelial cell membrane damage.37 Antidepressant drugs, which are represented by the 
descriptor 6, could induce ocular phototoxicity.38 The patients on antidepressants or 
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undergoing neurological therapy are reported to be susceptible to retinal irritation and 
toxicity.38–40 There is no evidence about the relationship between ocular toxicity and esters 
(descriptor 4, Table 2). On the contrary, the esters are reported to be used to treat ocular 
infections.41 In our model, it could be considered as a negative modulator. As compared to 
esters, the carboxylic acids, which are represented by descriptor 8, can cause burns on the 
eyes.42 The remaining two descriptors (descriptors 5 and 7, Table 2) have obscure 
relationships with chemical ocular toxicity. Although ocular toxicity was observed with the 
amines (e.g., triethylamine43), this effect is most likely due not to a specific property of the 
chemical but rather to the alkaline nature of aliphatic amines.
Advantages and Pitfalls of the Consensus Model
To stress the advantage of the consensus model using the combi-QSAR technique, it should 
be made clear that from the viewpoint of toxicologists and other biologists that QSAR 
modeling is always a tool to analyze how the change of functional groups affects biological 
activity for a generic set of compounds. On the basis of this hypothesis, most of the 
traditional QSAR studies used a single modeling approach to develop a single model based 
on one type of descriptors. The assumption that “similar structures yield similar properties” 
runs contrary to the use of the traditional QSAR workflow for data sets with diverse 
compounds. As compared to traditional data mining and data modeling procedures (e.g., 
modeling by using one statistical tool and one type of descriptors), this study focuses on 
prediction based on a combination of various types of models (by using different statistical 
tools and different types of chemical descriptors). Consensus modeling based on the combi-
QSAR workflow will take advantage of the output from each individual model and utilize 
most optimally the chemical and/or biological information of the diverse chemical data set. 
On the other hand, the combi-QSAR modeling is more time-consuming than the 
development of a single model.
It needs to be noted that the prediction values of all individual models and that of the 
consensus model range from 0 to 1, and we set the classification threshold as 0.5 to 
determine toxic and nontoxic predictions. Table 3 shows the experimental and predicted 
ocular toxicity results of several sample compounds from the external set. In most cases, the 
consensus model could compensate for the errors from individual models (e.g., the 
predictions of compounds #2 and #3). However, the last compound was predicted incorrectly 
by all individual models, and the consensus model failed as well. In this case, our modeling 
results indicate that we are lacking necessary information in the modeling set for compounds 
with such a chemical scaffold. Therefore, compounds similar to compound #4 in Table 3 
should be tested experimentally with higher priority in the future as this would allow 
knowledge gaps to be addressed and for the improvement of computational models.
CONCLUSIONS
In this study, several QSAR approaches have been used to develop predictive models of the 
largest publicly available regulatory ocular toxicity set of diverse organic compounds. Every 
compound in this data set has been extensively evaluated for its eye irritation effect by the 
Draize test. Three regulatory agencies categorized these compounds using their own scoring 
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system based on Draize test results. We used a composite score to classify all of the 
compounds into ocular toxicants and nontoxicants. This composite score has high 
correlation with all three regulatory scoring systems. The resulting models were validated by 
predicting the toxicity of an external validation set compiled from different sources. It was 
observed that all models showed comparable performance for the external validation set. 
The most significant result of our studies is the demonstrated superior performance of the 
consensus modeling approach when all models are used concurrently and predictions from 
individual models are averaged. The predictive accuracy of the consensus QSAR models 
was shown to be superior to any individual models when predicting the same set of external 
compounds. The models reported in this paper could be used to evaluate the ocular toxicity 
of new organic compounds. Meanwhile, we invite all interested researchers to send us 
compounds for ocular toxicity prediction.
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Experimental animal ocular toxicity results for 75 ICCVAM compounds.
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Combinatorial QSAR modeling workflow.
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Chemical space of the ICCVAM modeling set (purple, n = 75) and external validation set 
(red, n = 34) shown as first three principle components (57% explained variance) of 186 
two-dimensional MOE descriptors using MOE 2011.
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Performance on external set (n = 34) of four individual QSAR models and their consensus 
model.
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Table 1
Transformation of Different Regulatory Scoring Systems of Chemical Ocular Toxicity into Binary Composite 
Classifications in This Study
GHS U.S. EPA EU composite
severe ocular toxicants category 1 category I R41 “toxic” (active)
moderate ocular toxicants category 2A category II R36 “toxic” (active)
light ocular toxicants category 2B category III “nontoxic” (inactive)
nontoxicants nonirritant category IV nonirritant “nontoxic” (inactive)
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